Advancements in Cell and Gene Therapy: 2019 Year-in-Review

Quality Starting Material: The Driving Force Behind Life-Saving Cell Therapies

By Jamie Margolis, PhD, Senior Vice President of Donor Services, NMDP/Be The Match

The benefits of a Quality System Audit Program

Accelerate patient access to cell and gene therapies

Standardization in cell therapy industry is a race against time

Accellerate Summit highlights needs and challenges in standardization

The challenge of multiple audits and redundant training

A case study from UCLA Health

Industry stakeholders propose unified CAR T toxicity grading scale

CIBMTR Cellular Therapy Registry recommended to meet outcomes data reporting requirements

Three things to know about efficient qualification of collection centers

Advancements in Cell Therapy: 2018 Year-In-Review

How standardizing audits can help deliver high-quality therapies faster

Overview of the Quality System Audit Program